tiprankstipranks
Phibro Animal Health (PAHC)
NASDAQ:PAHC

Phibro Animal Health Stock Analysis & Ratings

PAHC Stock Chart & Stats

Day’s Range$18.6 - $19.1
52-Week Range$17.28 - $31.00
Previous Close$18.53
Volume2.79K
Average Volume (3M)96.86K
Market Cap$768.35M
P/E Ratio12.8
Beta0.56
Next EarningsAug 29, 2022
Dividend Yield0.48 (2.62%)
Smart Score5
EPS (TTM)1.45


Phibro Animal Health News

Currently, no data available
Please return soon. This page is being updated.

---

Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

PAHC FAQ

What was Phibro Animal Health’s price range in the past 12 months?
Phibro Animal Health lowest stock price was $17.28 and its highest was $31.00 in the past 12 months.
    What is Phibro Animal Health’s market cap?
    Phibro Animal Health’s market cap is $768.35M.
      What is Phibro Animal Health’s price target?
      The average price target for Phibro Animal Health is $22.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $22.00 ,the lowest forecast is $22.00. The average price target represents 15.97% Increase from the current price of $18.97.
        What do analysts say about Phibro Animal Health?
        Phibro Animal Health’s analyst rating consensus is a ‘Hold. This is based on the ratings of 1 Wall Streets Analysts.
          When is Phibro Animal Health’s upcoming earnings report date?
          Phibro Animal Health’s upcoming earnings report date is Aug 29, 2022 which is in 104 days.
            How were Phibro Animal Health’s earnings last quarter?
            Phibro Animal Health released its earnings results on May 04, 2022. The company reported $0.33 earnings per share for the quarter, missing the consensus estimate of $0.353 by -$0.023.
              Is Phibro Animal Health overvalued?
              According to Wall Street analysts Phibro Animal Health’s price is currently Undervalued.
                Does Phibro Animal Health pay dividends?
                Phibro Animal Health pays a Quarterly dividend of $0.12 which represents an annual dividend yield of 2.62%. Phibro Animal Health’s last Quarterly dividend payment was on Jun 22, 2022. Phibro Animal Health’s upcoming ex-dividend date is May 31, 2022
                  What is Phibro Animal Health’s EPS estimate?
                  Phibro Animal Health’s EPS estimate for its next earnings report is not yet available.
                  How many shares outstanding does Phibro Animal Health have?
                  Phibro Animal Health has 40,500,000 shares outstanding.
                    What happened to Phibro Animal Health’s price movement after its last earnings report?
                    Phibro Animal Health reported an EPS of $0.33 in its last earnings report, missing expectations of $0.353. Following the earnings report the stock price went down -9.109%.
                      Which hedge fund is a major shareholder of Phibro Animal Health?
                      Among the largest hedge funds holding Phibro Animal Health’s share is Pzena Investment Management LLC. It holds Phibro Animal Health’s shares valued at 32M.

                        ---

                        Phibro Animal Health Stock Analysis

                        Smart Score
                        5
                        Neutral
                        1
                        2
                        3
                        4
                        5
                        6
                        7
                        8
                        9
                        10
                        Price Target
                        $22.00
                        ▲(15.97% Upside)
                        Hold
                        The Phibro Animal Health stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                        Learn more about TipRanks Smart Score

                        Company Description

                        Phibro Animal Health

                        Phibro Animal Health Corp. engages in the manufacture of animal health and mineral nutrition products. It operates through the following business segments: Animal Health, Mineral Nutrition, and Performance Products. The Animal Health segment develops, manufactures, and markets antibacterial, nutritional specialty products, and vaccines. The Mineral Nutrition segment comprises of the formulations and concentrations of trace minerals such as zinc, manganese, copper, iron, and compounds. The Performance Products segment offers production of specialty ingredients for use in the personal care, automotive, industrial chemical, and chemical catalyst industries. The company was founded on May 11, 1946 and is headquartered in Teaneck, NJ.

                        ---
                        Similar Stocks
                        Company
                        Price & Change
                        Follow
                        Zoetis
                        Jaguar Animal Health
                        Merck & Company
                        Immucell
                        Eli Lilly & Co

                        Popular Stocks

                        ---
                        What's Included in PREMIUM?
                        Make informed decisions based on Top Analysts' activity
                        Know what industry insiders are buying
                        Get actionable alerts from top Wall Street Analysts
                        Find out before anyone else which stock is going to shoot up
                        Get powerful stock screeners & detailed portfolio analysis